07:00 , Oct 3, 2016 |  BC Week In Review  |  Company News

Ben-Gurion University, Hadassah Medical Organization, BioLineRx deal

The organization’s Hadasit Medical Research Services & Development Ltd. technology transfer arm and the university’s BGN Technologies technology transfer arm granted BioLineRx exclusive, worldwide rights to BL-1220 , a preclinical liver fibrosis and non-alcoholic steatohepatitis...
08:00 , Dec 14, 2015 |  BC Week In Review  |  Clinical News

BL-8040: Phase I/II started

BioLine began an open-label, U.S. Phase I/II trial to evaluate subcutaneous BL-8040 plus standard immunotherapy in up to 25 patients. Patients will receive 0.75 mg/kg BL-8040 on days 1-10, then on the first 5 days...
07:00 , May 5, 2014 |  BC Week In Review  |  Company News

Alere, Malaria No More diagnostic news

Alere delivered 1 million Alere SD BIOLINE Malaria Rapid tests to Zambia through Malaria No More's Power of One Campaign. As Malaria No More's exclusive diagnostics partner, Alere is donating a total of 2 million...
08:00 , Dec 10, 2012 |  BC Week In Review  |  Company News

Meridian Bioscience sales and marketing update

Meridian said its Bioline subsidiary launched the SensiFast Genotyping Kit worldwide. The kit detects sequence variants including loci with type IV SNPs. The list price of 200 reactions is $130. Meridian Bioscience Inc. (NASDAQ:VIVO), Cincinnati,...
07:00 , Oct 8, 2012 |  BC Week In Review  |  Company News

BioLine LLC, Curetis sales and marketing update

Curetis granted BioLine exclusive rights to distribute Curetis' Unyvero system and Unyvero P50 Pneumonia application cartridge in Russia, Ukraine, Kazakhstan and Belarus. Curetis said BioLine is preparing to register the products with the Russian Ministry...
08:00 , Feb 20, 2012 |  BC Week In Review  |  Company News

Meridian Bioscience sales and marketing update

Meridian's Bioline USA Inc. subsidiary launched SensiFAST HRM Kit. The kit uses high resolution melting to detect gene mutations and analyze SNPs under its SensiFAST family of real-time PCR products. Meridian Bioscience Inc. (NASDAQ:VIVO), Cincinnati,...
07:00 , Jul 26, 2010 |  BC Week In Review  |  Company News

Bioline, Meridian Bioscience deal

Bioline , London, U.K.   Meridian Bioscience Inc. (NASDAQ:VIVO), Cincinnati, Ohio   Business: Supply/Service   Meridian acquired molecular reagents company Bioline for $23.3 million in cash. Meridian said the deal will add to its life...
08:00 , Jan 18, 2010 |  BC Week In Review  |  Company News

Inverness, Standard Diagnostics deal

Inverness began a tender offer to acquire up to 75.8% of Standard Diagnostics at KRW40,000 per share, or about KRW242.5 billion ($218.3 million). The price is a 5.7% premium to Standard Diagnostics' close price of...